These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26076009)

  • 21. A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening.
    Jänne PA; Borras AM; Kuang Y; Rogers AM; Joshi VA; Liyanage H; Lindeman N; Lee JC; Halmos B; Maher EA; Distel RJ; Meyerson M; Johnson BE
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):751-8. PubMed ID: 16467085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing.
    Moskalev EA; Frohnauer J; Merkelbach-Bruse S; Schildhaus HU; Dimmler A; Schubert T; Boltze C; König H; Fuchs F; Sirbu H; Rieker RJ; Agaimy A; Hartmann A; Haller F
    Lung Cancer; 2014 Jun; 84(3):215-21. PubMed ID: 24674157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malfeasance of KRAS mutations in carcinogenesis.
    Tripathi R; Nathany S; Mehta A; Batra U; Mattoo S; Sharma M
    Clin Exp Med; 2021 Aug; 21(3):439-445. PubMed ID: 33709341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison study of the performance of the QIAGEN EGFR RGQ and EGFR pyro assays for mutation analysis in non-small cell lung cancer.
    Cushman-Vokoun AM; Crowley AM; Rapp SA; Greiner TC
    Am J Clin Pathol; 2013 Jul; 140(1):7-19. PubMed ID: 23765529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of an Australian testing programme for epidermal growth factor receptor mutations in non-small cell lung cancer.
    Peters MJ; Bowden JJ; Carpenter P; Lewis J; Solomon B
    Intern Med J; 2014 Jun; 44(6):575-80. PubMed ID: 24720523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.
    Chu H; Zhong C; Xue G; Liang X; Wang J; Liu Y; Zhao S; Zhou Q; Bi J
    Oncol Rep; 2013 Nov; 30(5):2311-5. PubMed ID: 24002698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-throughput diagnostic profiling of clinically actionable gene fusions in lung cancer.
    Pfarr N; Stenzinger A; Penzel R; Warth A; Dienemann H; Schirmacher P; Weichert W; Endris V
    Genes Chromosomes Cancer; 2016 Jan; 55(1):30-44. PubMed ID: 26394895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies.
    Fisher KE; Zhang L; Wang J; Smith GH; Newman S; Schneider TM; Pillai RN; Kudchadkar RR; Owonikoko TK; Ramalingam SS; Lawson DH; Delman KA; El-Rayes BF; Wilson MM; Sullivan HC; Morrison AS; Balci S; Adsay NV; Gal AA; Sica GL; Saxe DF; Mann KP; Hill CE; Khuri FR; Rossi MR
    J Mol Diagn; 2016 Mar; 18(2):299-315. PubMed ID: 26801070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
    Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
    J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EGFR array: uses in the detection of plasma EGFR mutations in non-small cell lung cancer patients.
    Yam I; Lam DC; Chan K; Chung-Man Ho J; Ip M; Lam WK; Chan TK; Chan V
    J Thorac Oncol; 2012 Jul; 7(7):1131-40. PubMed ID: 22610259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel point-of-care system for high-speed real-time polymerase chain reaction testing for epidermal growth factor receptor mutations in bronchial lavage fluids after transbronchial biopsy in patients with non-small cell lung cancer.
    Sakamoto T; Kodani M; Takata M; Chikumi H; Nakamoto M; Nishii-Ito S; Ueda Y; Izumi H; Makino H; Touge H; Takeda K; Yamasaki A; Yanai M; Tanaka N; Igishi T; Shimizu E
    Int J Oncol; 2015 Apr; 46(4):1473-80. PubMed ID: 25651992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance characteristics of the AmpliSeq Cancer Hotspot panel v2 in combination with the Ion Torrent Next Generation Sequencing Personal Genome Machine.
    Butler KS; Young MY; Li Z; Elespuru RK; Wood SC
    Regul Toxicol Pharmacol; 2016 Feb; 74():178-86. PubMed ID: 26387931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of epidermal growth factor receptor mutation in transbronchial needle aspirates of non-small cell lung cancer.
    Horiike A; Kimura H; Nishio K; Ohyanagi F; Satoh Y; Okumura S; Ishikawa Y; Nakagawa K; Horai T; Nishio M
    Chest; 2007 Jun; 131(6):1628-34. PubMed ID: 17565015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer.
    Shih JY; Gow CH; Yu CJ; Yang CH; Chang YL; Tsai MF; Hsu YC; Chen KY; Su WP; Yang PC
    Int J Cancer; 2006 Feb; 118(4):963-9. PubMed ID: 16152581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid detection of hotspot mutations in epidermal growth factor receptor by polymerase chain reaction facilitates the management of non-small cell lung cancer.
    Hung KS; Lee CN; Liu HE
    J Thorac Oncol; 2008 Oct; 3(10):1202-3. PubMed ID: 18827621
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumor gene mutations and messenger RNA expression: correlation with clinical response to icotinib hydrochloride in non-small cell lung cancer.
    Ren GJ; Zhao YY; Zhu YJ; Xiao Y; Xu JS; Shan B; Zhang L
    Chin Med J (Engl); 2011 Jan; 124(1):19-25. PubMed ID: 21362302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers.
    D'Haene N; Le Mercier M; De Nève N; Blanchard O; Delaunoy M; El Housni H; Dessars B; Heimann P; Remmelink M; Demetter P; Tejpar S; Salmon I
    PLoS One; 2015; 10(9):e0138245. PubMed ID: 26366557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A useful protocol for analyses of mutations of the epidermal growth factor receptor gene.
    Liu D; Nakano J; Ueno M; Masuya D; Nakashima T; Yokomise H; Yube K; Huang CL
    Oncol Rep; 2006 Jun; 15(6):1503-5. PubMed ID: 16685386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and comparison of epidermal growth factor receptor mutations in cells and fluid of malignant pleural effusion in non-small cell lung cancer.
    Zhang X; Zhao Y; Wang M; Yap WS; Chang AY
    Lung Cancer; 2008 May; 60(2):175-82. PubMed ID: 18061305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of EGFR gene mutations using the wash fluid of CT-guided biopsy needle in NSCLC patients.
    Otani H; Toyooka S; Soh J; Yamamoto H; Suehisa H; Kobayashi N; Gobara H; Mimura H; Kiura K; Sano Y; Kanazawa S; Date H
    J Thorac Oncol; 2008 May; 3(5):472-6. PubMed ID: 18448998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.